Autoimmune pancreatitis often mimics pancreatic cancer, and for clinicians, distinguishing Type 1 (IgG4) from Type 2 (IBD) is ...
Insilico Medicine ("Insilico"), a global leader in AI-powered drug discovery, and Atossa Therapeutics ("Atossa") (Nasdaq: ATOS), a clinical-stage biopharmaceutical company developing novel treatments ...
Keith Speights has positions in Amazon, MercadoLibre, and Vertex Pharmaceuticals. The Motley Fool has positions in and recommends Amazon, MercadoLibre, TransMedics Group, and Vertex Pharmaceuticals.
News-Medical.Net on MSN
Generative AI aids discovery of ISM3830's novel scaffold
Casitas B-lineage lymphoma-b (CBLB) is an E3 ubiquitin–protein ligase that functions as an intracellular checkpoint and master negative regulator of T‑cell and natural killer (NK) cell activation, ...
Insilico's generative AI platform, Chemistry42, successfully designed a first-in-class PROTAC targeting PKMYT1 by creating an entirely new inhibitor and its complex linker, demonstrating a powerful, ...
Insilico Medicine ("Insilico"), a global leader in AI-powered drug discovery, and Atossa Therapeutics ("Atossa") (Nasdaq ...
Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced the European Patent Office (EPO) has issued patent No. 4 496 611 ...
Executive Women of New Jersey (EWNJ), the state's leading organization for women executives, today awarded $35,000 in scholarships to seven outstanding women graduate students as part of the ...
ANI’s FutureVision Advisory Council is co-led by Arshad M. Khanani, MD, MA, FASRS, who serves as Principal Retina Advisor and Chair, and Peter Chang, MD, FACS who serves as Principal Uveitis Advisor ...
Citi Annual Global Healthcare Conference 2025 December 2, 2025 11:15 AM ESTCompany ParticipantsWilliam Meury - CEO, ...
Columnist Samuel Kirton shares his emergency "go bag" checklist of things he brought when he received a bilateral lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results